Global Testosterone Replacement Therapy Market to Grow 3.35% by 2020 - FDA Warnings on Use of Testosterone Products a Key Challenge - Research and Markets

DUBLIN, August 12, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Global Testosterone Replacement Therapy Market 2016-2020" report to their offering.

The report forecasts the global testosterone replacement therapy market is gradually declining and will post a CAGR of (3.35) % during the period 2016-2020.

The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

According to the report, increase in older population will be a key driver for market growth. Age related lowering of testosterone presents features both primary and secondary hypogonadism. Improved healthcare infrastructure and sophisticated treatment facilities have increased life expectancy of individuals. This has led to an increase in older adult population worldwide.

Further, the report states that generic erosion will be a challenge for the market. The entry of generic drugs in the market results in the decline in the overall market revenue, thus affecting the growth of the market. Though all marketed drugs have not lost their respective patents, generic testosterone formulations are available in the market. The branded versions of the drug costs around $300 - $350 per month and generic versions of testosterone shots can be obtained at as low as $20 per dose. Thus, the generic erosion of drugs acts as a challenge for the growth of the market.

Key vendors:

• AbbVie
• Allergan
• Eli Lilly and Company
• Endo Pharmaceuticals

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Market research methodology

PART 04: Introduction

PART 05: Hypogonadism

PART 06: Pipeline analysis

PART 07: Key buying criteria

PART 08: Market landscape

PART 09: Market segmentation by dosage form

PART 10: Geographical segmentation

PART 11: Market drivers

PART 12: Impact of drivers

PART 13: Market challenges

PART 14: Impact of drivers and challenges

PART 15: Market trends

PART 16: Vendor landscape

PART 17: Appendix

For more information about this report visit http://www.researchandmarkets.com/research/tpn38c/global

Media Contact:

Research and Markets

Laura Wood, Senior Manager

[e-mail]

For E.S.T Office Hours Call [phone]

For U.S./CAN Toll Free Call [phone]

For GMT Office Hours Call [phone]

U.S. Fax: [phone]

Fax (outside U.S.): [phone]